About the Solid Tumor Programs
The Solid Tumor Programs at Texas Children’s Cancer Center provide cutting-edge clinical care for children with tumors of the bone, soft tissue, kidney, liver and other organs.
Our programs provide a multidisciplinary team of experts who collaborate in the care of each patient and in the development and execution of cutting-edge clinical trials to improve outcomes for these patients. We treat patients with a wide variety of solid tumors and cancers, including:
- Ewing sarcoma
- Germ cell tumor
- Liver tumor
- Kidney tumor
- Bone tumor
- Thyroid cancer
Our physicians have extensive expertise in the treatment of rare tumors such as hepatoblastoma and hepatocellular carcinoma (liver tumors), germ cell tumors (tumors of the reproductive organs), sarcomas of the soft tissues and many other cancers. In addition, the Solid Tumor Programs have a special interest in the study of vascular tumors (hemangiomas, vascular malformations and malignancies). Seeing over 150 new patients a year, we are one of the largest pediatric solid tumor programs in the country.
Our investigators play leadership roles at the national level through participation in the solid tumor clinical research efforts of the National Cancer Institute-sponsored Children’s Oncology Group (COG). We use translational research to initiate clinical trials. Examples of these include promising phase I vaccine trials in the management of neuroblastoma and engineered T cell therapy for osteosarcoma. Our comprehensive program also focuses on the genetic composition of osteosarcoma and potential of osteosarcoma cells to spread to distant organs. We are also examining how genome sequencing can eventually lead to better outcomes for children with solid tumors.
Donations and Giving
You may specify a disease category under ‘Purpose of Donation.’